Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay

References

• Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46(4):584–587. doi:10.1067/mjd.2002.120625
   PubMed Web of Science ®Google Scholar
• Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282–289.
   PubMed Web of Science ®Google Scholar
• Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47(5):497–502. doi:10.1111/1346-8138.15301
   PubMed Web of Science ®Google Scholar
• Zuo Z, Wang B, Shen M, et al. Skincare habits and rosacea in 3439 Chinese adolescents: a university-based cross-sectional study. Acta Derm Venereol. 2020;100(6):adv00081. doi:10.2340/00015555-3442
   PubMed Web of Science ®Google Scholar
• Bewley A, Fowler J, Schöfer H, Kerrouche N, Rives V. Erythema of rosacea impairs health-related quality of life: results of a meta-analysis. Dermatol Ther (Heidelb). 2016;6(2):237–247. doi:10.1007/s13555-016-0106-9
   PubMed Web of Science ®Google Scholar
• Wang Z, Xie H, Gong Y, et al. Relationship between rosacea and sleep. J Dermatol. 2020;47(6):592–600. doi:10.1111/1346-8138.15339
   PubMed Web of Science ®Google Scholar
• Tan J, Steinhoff M, Bewley A, Gieler U, Rives V. Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey. J Dermatolog Treat. 2020;31(2):168–174. doi:10.1080/09546634.2019.1623368
   PubMed Web of Science ®Google Scholar
• Basra MK, Shahrukh M. Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res. 2009;9(3):271–283. doi:10.1586/erp.09.23
   PubMedGoogle Scholar
• Halioua B, Cribier B, Frey M, Tan J. Feelings of stigmatization in patients with rosacea. J Eur Acad Dermatol Venereol. 2017;31(1):163–168. doi:10.1111/jdv.13748
   PubMed Web of Science ®Google Scholar
• Böhm D, Schwanitz P, Stock GS, Schmid-Ott G, Schulz W. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med. 2014;19(5):586–591. doi:10.1080/13548506.2013.841968
   PubMed Web of Science ®Google Scholar
• Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19(6):488–495. doi:10.1002/cpp.763
   PubMed Web of Science ®Google Scholar
• Johnston SA, Krasuska M, Millings A, Lavda AC, Thompson AR. Experiences of rosacea and its treatment: an interpretative phenomenological analysis. Br J Dermatol. 2018;178(1):154–160. doi:10.1111/bjd.15780
   PubMed Web of Science ®Google Scholar
• Jansea AJ, Gemkeb RJ, Uiterwaalc CS, Tweeld I, Kimpena JLL, Sinnema G. Quality of life: patients and doctors don’t always agree: a meta-analysis. J Clin Epidemiol. 2004;57(7):653–661. doi:10.1016/j.jclinepi.2003.11.013
   PubMed Web of Science ®Google Scholar
• Seidler AM, Bayoumi AM, Goldstein MK, Cruz PD Jr., Chen SC. Willingness to pay in dermatology: assessment of the burden of skin diseases. J Invest Dermatol. 2012;132(7):1785–1790. doi:10.1038/jid.2012.50
   PubMed Web of Science ®Google Scholar
• Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134–139. doi:10.1111/j.1365-2133.2009.09091.x
   PubMed Web of Science ®Google Scholar
• Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429–435. doi:10.1111/j.1468-3083.2010.03808.x
   PubMed Web of Science ®Google Scholar
• Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306(3):279–286. doi:10.1007/s00403-013-1402-1
   PubMed Web of Science ®Google Scholar
• Larsen MH, Strumse YAS, Borge CR, Osborne R, Andersen MH, Wahl AK. Health literacy: a new piece of the puzzle in psoriasis care? A cross-sectional study. Br J Dermatol. 2019;180(6):1506–1516. doi:10.1111/bjd.17595
   PubMed Web of Science ®Google Scholar
• He Z, Lu C, Basra MK, Ou A, Yan Y, Li L. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(1):109–115. doi:10.1111/j.1468-3083.2011.04371.x
   PubMed Web of Science ®Google Scholar
• Lesner K, Reich A, Szepietowski JC, et al. Determinants of psychosocial health in psoriatic patients: a multi-national study. Acta Derm Venereol. 2017;97(10):1182–1188. doi:10.2340/00015555-2760
   PubMed Web of Science ®Google Scholar
• Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global rosacea consensus 2019 panel. Br J Dermatol. 2020;182(5):1269–1276. doi:10.1111/bjd.18420
   PubMed Web of Science ®Google Scholar
• Seidler AM, Kini SP, DeLong LK, Veledar E, Chen SC. Preference-based measures in dermatology: an overview of utilities and willingness to pay. Dermatol Clin. 2012;30(2):223–229. doi:10.1016/j.det.2011.12.002
   PubMed Web of Science ®Google Scholar
• Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol. 2013;27(6):734–738. doi:10.1111/j.1468-3083.2012.04549.x
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148–155. doi:10.1016/j.jaad.2017.08.037
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
   PubMed Web of Science ®Google Scholar
• Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J Invest Dermatol. 2005;125(4):659–664. doi:10.1111/j.0022-202X.2005.23621.x
   PubMed Web of Science ®Google Scholar
• Augustin M, Blome C, Forschner A, et al. Willingness to pay for a cure of low-risk melanoma patients in Germany. PLoS One. 2018;13(5):e0197780. doi:10.1371/journal.pone.0197780
   PubMed Web of Science ®Google Scholar
• Wollina U. Is rosacea a systemic disease? Clin Dermatol. 2019;37(6):629–635. doi:10.1016/j.clindermatol.2019.07.032
   PubMed Web of Science ®Google Scholar
• Zhang H, Tang K, Wang Y, Fang R, Sun Q. Rosacea treatment: review and update. Dermatol Ther (Heidelb). 2021;11(1):13–24. doi:10.1007/s13555-020-00461-0
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang N. Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China. Patient Prefer Adherence. 2017;11:151–155. doi:10.2147/PPA.S121218
   PubMed Web of Science ®Google Scholar
• Yu NL, Tan H, Song ZQ, Yang XC. Illness perception in patients with androgenetic alopecia and alopecia areata in China. J Psychosom Res. 2016;86:1–6. doi:10.1016/j.jpsychores.2016.04.005
   PubMed Web of Science ®Google Scholar
• Chen D, Tuan H, Zhou EY, Liu D, Zhao Y, Picardo M. Quality of life of adult vitiligo patients using camouflage: a survey in a Chinese vitiligo community. PLoS One. 2019;14(1):e0210581. doi:10.1371/journal.pone.0210581
   PubMed Web of Science ®Google Scholar
• An JG, Ma JH, Xiao SX, Xiao SB, Yang F. Quality of life in patients with lepromatous leprosy in China. J Eur Acad Dermatol Venereol. 2010;24(7):827–832. doi:10.1111/j.1468-3083.2009.03534.x
   PubMed Web of Science ®Google Scholar
• van der Linden MM, van Rappard DC, Daams JG, Sprangers MA, Spuls PI, de Korte J. Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015;95(4):395–400. doi:10.2340/00015555-1976
   PubMed Web of Science ®Google Scholar
• Li J, Li M, Chen Q, Fu J, Zhang M, Hao F. Quality of life among patients with rosacea: an investigation of patients in China using two structured questionnaires. J Eur Acad Dermatol Venereol. 2016;30(10):e98–e99. doi:10.1111/jdv.13341
   PubMed Web of Science ®Google Scholar
• Aksoy B, Altaykan-Hapa A, Egemen D, Karagöz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163(4):719–725. doi:10.1111/j.1365-2133.2010.09894.x
   PubMed Web of Science ®Google Scholar
• Wu Y, Fu C, Zhang W, Li C, Zhang J. The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients. Psychol Health Med. 2018;23(4):369–374. doi:10.1080/13548506.2017.1361540
   PubMed Web of Science ®Google Scholar
• Cardwell LA, Farhangian ME, Alinia H, Kuo S, Feldman SR. Psychological disorders associated with rosacea: analysis of unscripted comments. J Dermatol surg. 2015;19(2):99–103.
   Google Scholar
• Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140(2):273–282. doi:10.1046/j.1365-2133.1999.02662.x
   PubMed Web of Science ®Google Scholar
• Okhovat JP, Grogan T, Duan L, Goh C. Willingness to pay and quality of life in alopecia areata. J Am Acad Dermatol. 2017;77(6):1183–1184. doi:10.1016/j.jaad.2017.07.023
   PubMed Web of Science ®Google Scholar
• Schiffner R, Brunnberg S, Hohenleutner U, Stolz W, Landthaler M. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol. 2002;146(3):440–447. doi:10.1046/j.1365-2133.2002.04613.x
   PubMed Web of Science ®Google Scholar
• Stefanidou M, Evangelou G, Kontodimopoulos N, et al. Willingness to pay and quality of life in patients with pruritic skin disorders. Arch Dermatol Res. 2019;311(3):221–230. doi:10.1007/s00403-019-01900-5
   PubMed Web of Science ®Google Scholar